Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
Cycle-based dosing affects total annual costs for GHK-Cu
As the amount of the remaining drug in F 6 without any additives was about 40 percent (Table 2), these findings showed that the presence of additives in those has destabilized vitamin B 12 and according to Table 1, PEG and PG 50% v/v as solubilizing and tonicity-adjusting agents, EDTA 0.05% w/v as a chelating agent, S.M.O 0.025%v/v as a surfactant and S.F.S 10% w/v as an antioxidant cannot be considered as stabilizing agents in the case of this study
An enzyme that degrades these problematic peptides could prevent the harmful immune response, and Helmerhorst was prepared to sift through saliva to find it
BPC-157s potent anti-inflammatory effects, particularly in the gut where 70% of your immune system resides, can reduce systemic inflammatory burden
